Palomar Medical Tech (PMTI) Posts Q2 Loss of 8c/Share
Tweet
Share
E-mailGet Alerts PMTI Hot Sheet
Price: $13.41 --0%
Financial Fact:
Cost of royalty revenues: 791.76K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of royalty revenues: 791.76K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Palomar Medical Tech (NASDAQ: PMTI) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $19.7 million versus the consensus estimate of $19.99 million.
For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.
For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
